Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)

被引：150

作者：

Cheng, Shuqun ^{[1
]}

Chen, Minshan ^{[2
]}

Cai, Jianqiang ^{[3
]}

Sun, Juxian ^{[1
]}

Guo, Rongping ^{[2
]}

Bi, Xinyu ^{[3
]}

Lau, Wan Yee ^{[1
,4
]}

Wu, Mengchao ^{[1
]}

机构：

[1] Second Mil Med Univ, Dept Hepat Surg 6, Eastern Hepatobiliary Surg Hosp, Changhai Rd 168, Shanghai 200433, Peoples R China

[2] Sun Yat Sen Univ, Dept Hepatobiliary Surg, Ctr Canc, 651 Dongfeng Rd East, Guangzhou 510060, Peoples R China

[3] Chinese Acad Med Sci, Dept Hepatobiliary Surg, Canc Hosp, South 17, Beijing 100021, Peoples R China

[4] Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China

来源：

LIVER CANCER | 2020年 / 9卷 / 01期

关键词：

Hepatocellular carcinoma; Portal vein tumor thrombus; Multidisciplinary therapy; Consensus; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; STEREOTACTIC BODY RADIOTHERAPY; INDUCED LIVER-DISEASE; LONG-TERM OUTCOMES; TRANSARTERIAL CHEMOEMBOLIZATION; MACROVASCULAR INVASION; SURGICAL-TREATMENT; RADIATION-THERAPY; CANCER STATISTICS; DOUBLE-BLIND;

D O I：

10.1159/000503685

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Portal vein tumor thrombus (PVTT) is very common, and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the Consensus in 2016. Over the past several years, many new evidences for the treatment of PVTT become available especially for the advent of new targeted drugs which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer revised the 2016 version of consensus to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials.

引用

页码：28 / 40

页数：13

共 79 条

[1]

Ajit Yadav, 2014, Oman Med J, V29, P430, DOI 10.5001/omj.2014.114

[2]

[Anonymous], GRAD DEF SUGG PRACT

[3] Radiation induced liver disease: A clinical update [J].

Benson, R. ;

Madan, R. ;

Kilambi, R. ;

Chander, S. .

JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2016, 28 (01) :7-11

[4] Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone [J].

Brown, Karen T. ;

Do, Richard K. ;

Gonen, Mithat ;

Covey, Anne M. ;

Getrajdman, George I. ;

Sofocleous, Constantinos T. ;

Jarnagin, William R. ;

D'Angelica, Michael I. ;

Allen, Peter J. ;

Erinjeri, Joseph P. ;

Brody, Lynn A. ;

O'Neill, Gerald P. ;

Johnson, Kristian N. ;

Garcia, Alessandra R. ;

Beattie, Christopher ;

Zhao, Binsheng ;

Solomon, Stephen B. ;

Schwartz, Lawrence H. ;

DeMatteo, Ronald ;

Abou-Alfa, Ghassan K. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (17) :2046-+

[5] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Bruix, Jordi ;

Qin, Shukui ;

Merle, Philippe ;

Granito, Alessandro ;

Huang, Yi-Hsiang ;

Bodoky, Gyrogy ;

Pracht, Marc ;

Yokosuka, Osamu ;

Rosmorduc, Olivier ;

Breder, Valeriy ;

Gerolami, Rene ;

Masi, Gianluca ;

Ross, Paul J. ;

Song, Tianqiang ;

Bronowicki, Jean-Pierre ;

Ollivier-Hourmand, Isabelle ;

Kudo, Masatoshi ;

Cheng, Ann-Lii ;

Llovet, Josep M. ;

Finn, Richard S. ;

LeBerre, Marie-Aude ;

Baumhauer, Annette ;

Meinhardt, Gerold ;

Han, Guohong .

LANCET, 2017, 389 (10064) :56-66

[6] Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial [J].

Bruix, Jordi ;

Takayama, Tadatoshi ;

Mazzaferro, Vincenzo ;

Chau, Gar-Yang ;

Yang, Jiamei ;

Kudo, Masatoshi ;

Cai, Jianqiang ;

Poon, Ronnie T. ;

Han, Kwang-Hyub ;

Tak, Won Young ;

Lee, Han Chu ;

Song, Tianqiang ;

Roayaie, Sasan ;

Bolondi, Luigi ;

Lee, Kwan Sik ;

Makuuchi, Masatoshi ;

Souza, Fabricio ;

Le Berre, Marie-Aude ;

Meinhardt, Gerold ;

Llovet, Josep M. .

LANCET ONCOLOGY, 2015, 16 (13) :1344-1354

[7] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial [J].

Bruix, Jordi ;

Raoul, Jean-Luc ;

Sherman, Morris ;

Mazzaferro, Vincenzo ;

Bolondi, Luigi ;

Craxi, Antonio ;

Galle, Peter R. ;

Santoro, Armando ;

Beaugrand, Michel ;

Sangiovanni, Angelo ;

Porta, Camillo ;

Gerken, Guido ;

Marrero, Jorge A. ;

Nadel, Andrea ;

Shan, Michael ;

Moscovici, Marius ;

Voliotis, Dimitris ;

Llovet, Josep M. .

JOURNAL OF HEPATOLOGY, 2012, 57 (04) :821-829

[8] Analysis of surgical treatment and prognostic factors for hepatocellular carcinoma with portal vein tumor thrombus [J].

Cao, Jingyu ;

Wang, Zusen ;

Wu, Shengkun ;

Yu, Yao ;

Zhu, Chengzhan ;

Wu, Liqun .

TRANSLATIONAL CANCER RESEARCH, 2017, 6 (01) :247-253

[9] Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016 [J].

Chan, Stephen L. ;

Chong, Charing C. N. ;

Chan, Anthony W. H. ;

Poon, Darren M. C. ;

Chok, Kenneth S. H. .

WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (32) :7289-7300

[10] Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial [J].

Chen, Qian ;

Shu, Chang ;

Laurence, Arian D. ;

Chen, Yan ;

Peng, Bao-Gang ;

Zhen, Zuo-Jun ;

Cai, Jian-Qiang ;

Ding, Yi-Tao ;

Li, Le-Qun ;

Zhang, Yu-Bao ;

Zheng, Qi-Chang ;

Xu, Ge-Liang ;

Li, Bo ;

Zhou, Wei-Ping ;

Cai, Shou-Wang ;

Wang, Xi-Yan ;

Wen, Hao ;

Peng, Xin-Yu ;

Zhang, Xue-Wen ;

Dai, Chao-Liu ;

Bie, Ping ;

Xing, Bao-Cai ;

Fu, Zhi-Ren ;

Liu, Lian-Xin ;

Mu, Yi ;

Zhang, Ling ;

Zhang, Qi-Shun ;

Jiang, Bin ;

Qian, Hai-Xin ;

Wang, Yi-Jun ;

Liu, Jing-Feng ;

Qin, Xi-Hu ;

Li, Qiang ;

Yin, Ping ;

Zhang, Zhi-Wei ;

Chen, Xiao-Ping .

GUT, 2018, 67 (11) :2006-2016

← 1 2 3 4 5 6 7 8 →